Piedmont Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-13,145
| Closed | -$461K | – | 1234 |
|
|
2019
Q1 | $461K | Buy |
13,145
+768
| +6% | +$26.9K | 0.02% | 570 |
|
|
2018
Q4 | $411K | Buy |
12,377
+409
| +3% | +$13.6K | 0.02% | 540 |
|
|
2018
Q3 | $603K | Sell |
11,968
-20,184
| -63% | -$1.02M | 0.03% | 443 |
|
|
2018
Q2 | $1.92M | Buy |
32,152
+21,137
| +192% | +$1.26M | 0.09% | 225 |
|
|
2018
Q1 | $504K | Buy |
11,015
+479
| +5% | +$21.9K | 0.01% | 413 |
|
|
2017
Q4 | $420K | Sell |
10,536
-508
| -5% | -$20.3K | 0.01% | 464 |
|
|
2017
Q3 | $442K | Buy |
11,044
+172
| +2% | +$6.88K | 0.01% | 460 |
|
|
2017
Q2 | $469K | Buy |
+10,872
| New | +$469K | 0.01% | 434 |
|